Cargando…

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study(1)(2)(3)

Background: Obesity is a serious chronic disease. Controlled-release phentermine/topiramate (PHEN/TPM CR), as an adjunct to lifestyle modification, has previously shown significant weight loss compared with placebo in a 56-wk study in overweight and obese subjects with ≥2 weight-related comorbiditie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garvey, W Timothy, Ryan, Donna H, Look, Michelle, Gadde, Kishore M, Allison, David B, Peterson, Craig A, Schwiers, Michael, Day, Wesley W, Bowden, Charles H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Nutrition 2012
Materias:	Obesity and Eating Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260065/ https://www.ncbi.nlm.nih.gov/pubmed/22158731 http://dx.doi.org/10.3945/ajcn.111.024927

Ejemplares similares

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
por: Allison, David B., et al.
Publicado: (2012)

Beneficial effects of a higher-protein breakfast on the appetitive, hormonal, and neural signals controlling energy intake regulation in overweight/obese, “breakfast-skipping,” late-adolescent girls(1)(2)(3)
por: Leidy, Heather J, et al.
Publicado: (2013)

Avocado Consumption Alters Gastrointestinal Bacteria Abundance and Microbial Metabolite Concentrations among Adults with Overweight or Obesity: A Randomized Controlled Trial
por: Thompson, Sharon V, et al.
Publicado: (2020)

Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials(1)(2)(3)
por: Johansson, Kari, et al.
Publicado: (2014)

Avocado Consumption, Abdominal Adiposity, and Oral Glucose Tolerance Among Persons with Overweight and Obesity
por: Khan, Naiman A, et al.
Publicado: (2021)

Healthy obesity and objective physical activity(1)(2)(3)
por: Bell, Joshua A, et al.
Publicado: (2015)

Prospective associations between problematic eating attitudes in midchildhood and the future onset of adolescent obesity and high blood pressure(1)(2)(3)
por: Wade, Kaitlin H, et al.
Publicado: (2017)

Lifestyle determinants of the drive to eat: a meta-analysis(1)(2)(3)
por: Chapman, Colin Daniel, et al.
Publicado: (2012)

Do Lower-Carbohydrate Diets Increase Total Energy Expenditure? An Updated and Reanalyzed Meta-Analysis of 29 Controlled-Feeding Studies
por: Ludwig, David S, et al.
Publicado: (2020)

A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesity(1)(2)(3)(4)
por: Foster, Gary D, et al.
Publicado: (2012)

Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods(1)(2)(3)
por: Byrne, Claire S, et al.
Publicado: (2016)

Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial(1)(2)(3)(4)
por: Tate, Deborah F, et al.
Publicado: (2012)

Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet, or restricted normal food: observational cohort study(1)(2)(3)
por: Hemmingsson, Erik, et al.
Publicado: (2012)

Energy Requirement Is Higher During Weight-Loss Maintenance in Adults Consuming a Low- Compared with High-Carbohydrate Diet
por: Ebbeling, Cara B, et al.
Publicado: (2020)

The Baby's First Bites RCT: Evaluating a Vegetable-Exposure and a Sensitive-Feeding Intervention in Terms of Child Health Outcomes and Maternal Feeding Behavior During Toddlerhood
por: van Vliet, Merel S, et al.
Publicado: (2021)

Assessing the causal role of adiposity on disordered eating in childhood, adolescence, and adulthood: a Mendelian randomization analysis
por: Reed, Zoe E, et al.
Publicado: (2017)

Acute Stress Exposure Alters Food-Related Brain Monoaminergic Profiles in a Rat Model of Anorexia
por: Reed, Carter H, et al.
Publicado: (2021)

Food Intake Following Gastric Bypass Surgery: Patients Eat Less but Do Not Eat Differently
por: Livingstone, M Barbara E, et al.
Publicado: (2022)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Biomarkers of browning of white adipose tissue and their regulation during exercise- and diet-induced weight loss(1)(2)
por: Nakhuda, Asif, et al.
Publicado: (2016)

No metabolic effects of mustard allyl-isothiocyanate compared with placebo in men
por: Langeveld, Mirjam, et al.
Publicado: (2017)

Inverse Association Between Hypothalamic N-Acetyl Aspartate/Creatine Ratio and Indices of Body Mass in Adolescents with Obesity
por: Neves, Thaysa Mara Gazzotto, et al.
Publicado: (2021)

Difference in Sugar-Sweetened Beverage Consumption before and during the COVID-19 Pandemic among Korean Adolescents
por: Park, Munsu, et al.
Publicado: (2023)

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
por: Shin, Jin Hee, et al.
Publicado: (2013)

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
por: Jordan, Jens, et al.
Publicado: (2014)

Cardiovascular Safety During and After Use of Phentermine and Topiramate
por: Ritchey, Mary E, et al.
Publicado: (2018)

Phentermine and topiramate for the management of obesity: a review
por: Cosentino, Gina, et al.
Publicado: (2011)

Phentermine-topiramate: First combination drug for obesity
por: Singh, Jagjit, et al.
Publicado: (2015)

A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
por: Kim, Anthony, et al.
Publicado: (2023)

17.1 Examining the Impact of COVID-19 on Adolescents With Eating Disorders
por: Spettigue, Wendy, et al.
Publicado: (2021)

A review of risk factors associated with insulin omission for weight loss in type 1 diabetes
por: Hall, Rebecca, et al.
Publicado: (2021)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting, Arianne N, et al.
Publicado: (2014)

Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report
por: Homola, Jaclyn, et al.
Publicado: (2018)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management
por: Garvey, William Timothy
Publicado: (2013)

Would you like fries with that? Investigating fast‐food outlet availability near schools in Perth, Western Australia
por: Trapp, Gina S. A., et al.
Publicado: (2022)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

ADHD as Sequel to Acute Disseminated Encephalomyelitis
por: Millichap, J. Gordon
Publicado: (2016)

Facilitators and barriers to a dietitian‐implemented blended care weight‐loss intervention (SMARTsize): a qualitative study
por: Heideman, W. H., et al.
Publicado: (2019)

Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release
por: Guo, Fangjian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_01afrkq3td5jt6rqk22logr6uq